Related Articles by Review for PMID: 30085601

Year	Number of Results
1995	2
1997	2
1998	3
1999	10
2000	1
2001	3
2002	2
2003	1
2004	1
2006	1
2008	2
2009	1
2010	1
2011	2
2012	1
2013	1
2017	1
2020	1
2021	1
2022	2
2024	1
2025	1

1

Jilani TN, Gibbons JR, Faizy RM, Saadabadi A. Jilani TN, et al. 2024 Nov 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Nov 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30085601 Free Books & Documents.

2

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group. Watanabe N, et al. CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. CNS Drugs. 2010. PMID: 20030418 Review.

3

Mirtazapine, an antidepressant.

Puzantian T. Puzantian T. Am J Health Syst Pharm. 1998 Jan 1;55(1):44-9. doi: 10.1093/ajhp/55.1.44. Am J Health Syst Pharm. 1998. PMID: 9437474 Review.

4

Mirtazapine: a review of its use in major depression and other psychiatric disorders.

Croom KF, Perry CM, Plosker GL. Croom KF, et al. CNS Drugs. 2009;23(5):427-52. doi: 10.2165/00023210-200923050-00006. CNS Drugs. 2009. PMID: 19453203 Review.

5

Pharmacology of antidepressants: selectivity or multiplicity?

Westenberg HG. Westenberg HG. J Clin Psychiatry. 1999;60 Suppl 17:4-8; discussion 46-8. J Clin Psychiatry. 1999. PMID: 10446734 Review.

6

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.

Fawcett J, Barkin RL. Fawcett J, et al. J Affect Disord. 1998 Dec;51(3):267-85. doi: 10.1016/s0165-0327(98)00224-9. J Affect Disord. 1998. PMID: 10333982 Review.

7

A risk-benefit assessment of mirtazapine in the treatment of depression.

Kasper S, Praschak-Rieder N, Tauscher J, Wolf R. Kasper S, et al. Drug Saf. 1997 Oct;17(4):251-64. doi: 10.2165/00002018-199717040-00005. Drug Saf. 1997. PMID: 9352961 Review.

8

Antidepressants: update on new agents and indications.

Ables AZ, Baughman OL 3rd. Ables AZ, et al. Am Fam Physician. 2003 Feb 1;67(3):547-54. Am Fam Physician. 2003. PMID: 12588077 Free article. Review.

9

Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.

Stimmel GL, Dopheide JA, Stahl SM. Stimmel GL, et al. Pharmacotherapy. 1997 Jan-Feb;17(1):10-21. Pharmacotherapy. 1997. PMID: 9017762 Review.

10

Mirtazapine: other indications.

Falkai P. Falkai P. J Clin Psychiatry. 1999;60 Suppl 17:36-40; discussion 46-8. J Clin Psychiatry. 1999. PMID: 10446741 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 30085601

40 results

Results by year